Moderna (CHIX:0QFD) OCF Yield %: -5.49 (As of Jun. 28, 2026)


CHIX:0QFD Moderna Inc CHIX:0QFD
58 GF Score
Price €42.71
GF Value €14.56
! 7 Warning Signs
View Full Analysis

What is Moderna OCF Yield %?

Moderna CHIX:0QFD 58 OCF Yield % is -5.49 as of Jun. 28, 2026. GuruFocus rates CHIX:0QFD with a GF Score™ of 58/100 and a GF Value™ of €14.56. The stock has 7 warning signs investors should review. Among 1,417 Biotechnology companies, Moderna ranks better than 57.45% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Moderna's Trailing 12-Month Cash Flow from Operations is €-1,269 Mil, and Market Cap is €23,494 Mil. Therefore, Moderna's OCF Yield % for today is -5.49%.

The historical rank and industry rank for Moderna's OCF Yield % or its related term are showing as below:

CHIX:0QFd' s OCF Yield % Range Over the Past 10 Years
Min: -32.61   Med: -4.91   Max: 24.77
Current: -5.49


During the past 10 years, the highest OCF Yield % of Moderna was 24.77%. The lowest was -32.61%. And the median was -4.91%.

CHIX:0QFd's OCF Yield % is ranked better than
57.45% of 1417 companies
in the Biotechnology industry
Industry Median: -8.4 vs CHIX:0QFd: -5.49

Moderna's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Moderna OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Moderna OCF Yield % Related Terms


Moderna OCF Yield % Historical Data

* Premium members only.

The historical data trend for Moderna's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moderna OCF Yield % Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -9.46 -19.39 -16.24

Moderna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.78 -34.66 -34.87 32.25 -17.11

CHIX:0QFD vs INCY, ROIV, JAZZ: OCF Yield % Comparison

For the Biotechnology subindustry, Moderna's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moderna OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moderna's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Moderna's OCF Yield % falls into.


CHIX:0QFD
58GF Score
Moderna Inc CHIX:0QFD
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moderna OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Moderna's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-1599.542 / 9850
=-16.24%

Moderna's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-544.95 * 4 / 12738.37444
=-17.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -5.49 mean?
Moderna (CHIX:0QFD) has a OCF Yield % of -5.49 as of Jun. 28, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Moderna and its competitors. According to the industry distribution chart, Moderna ranks #603 out of 1417 companies in the Biotechnology industry, placing it in the top 42.6%.
Is Moderna's OCF Yield % too high?
Moderna's current OCF Yield % is -5.49. Based on the distribution chart, Moderna ranks #603 out of 1417 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Moderna has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Moderna's OCF Yield % compare to INCY and ROIV?
According to the Biotechnology industry distribution chart, Moderna ranks #603 out of 1417 companies for OCF Yield %. This puts Moderna in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Moderna and its competitors. Moderna's current OCF Yield % is -5.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moderna stock overvalued right now?
Moderna (CHIX:0QFD) has a current OCF Yield % of -5.49. The stock's GF Value™ is €14.56, compared to a current price of €42.71 — trading 193.3% above its estimated fair value. The current OCF Yield % is -5.49. Moderna's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Moderna (CHIX:0QFD), the current OCF Yield % is -5.49 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moderna (CHIX:0QFD) Overvalued in 2026?

Based on GuruFocus' analysis, Moderna stock appears to be overvalued. The current stock price of €42.71 is trading 193.3% above its estimated GF Value™ of €14.56.

Key valuation signals for CHIX:0QFD:

  • OCF Yield %: -5.49
  • GF Value™: €14.56 vs. price of €42.71 (193.3% above fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the CHIX:0QFD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Moderna Business Description

Address 325 Binney Street, Cambridge, MA, USA, 02142
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
58GF Score

Get the complete analysis for CHIX:0QFD

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€42.71
Price
€14.56
GF Value